Abstract
Six Japanese children with rapidly progressive Henoch-Schönlein purpura nephritis (HSPN) received multiple drug therapy combined with plasmapheresis (PP). After five courses of PP, multiple drug therapy, including methylprednisolone and urokinase pulse therapy, oral prednisolone, cyclophophamide, dipyridamole, and warfarin was given. At presentation, urine protein excretion and histological indices of the mean activity and chronicity were 245±101 mg/m2 per hour, 6.6±1.2, and 1.5±1.3, respectively. After 6 months of therapy, urinary protein excretion had decreased significantly (P<0.001). The activity index decreased significantly at the second renal biopsy performed at a mean interval of 4.3 months after the first (2.8±1.4, P<0.05), while the chronicity index did not change. At the most recent observation, all showed clinical improvement. Two patients had normal urine, three had proteinuria of <20 mg/m2 per hour, one had proteinuria of >20 mg/m2 per hour, and none had renal insufficiency. Although this case series is without controls, our treatment protocol may be of benefit to children with rapidly progressive HSPN.
This is a preview of subscription content, log in via an institution to check access.
References
Habib R, Niaudet R, Levy M (1994) Schoenlein-Henoch purpura nephritis and IgA nephropathy. In: Tisher CC, Brenner BM (eds) Renal pathology with clinical and functional correlations, 2nd edn. Lippincott, Philadelphia, pp 427–523
Counahan R, Winterborn MH, White RHR (1977) Prognosis of Henoch-Schoenlein nephritis in children. BMJ 2:11–14
Niaudet P, Habib R (1998) Methylprednisolone pulse therapy in the treatment of severe forms of Schoenlein-Henoch purpura nephritis. Pediatr Nephrol 12:238–243
Coppo R, Basolo B, Roccatello D, Piccoli G (1985) Plasma exchange in primary IgA nephropathy and Henoch-Schoenlein purpura syndrome nephritis. Plasma Ther Transfus Technol 6:705–723
Iijima K, Ito-Kariya S, Nakamura H, Yoshikawa N (1998) Multiple combined therapy for severe Henoch-Schoenlein nephritis in children. Pediatr Nephrol 12:244–248
Hattori M, Ito K, Konomoto T, Kawaguchi H, Yoshioka T, Khono M (1999) Plasmapheresis as the sole therapy for rapidly progressive Schoenlein-Henoch purpura nephritis in children. Am J Kidney Dis 33:427–433
Kawasaki Y, Suzuki J, Nozawa R, Suzuki S, Suzuki H (2003) Efficacy of methylprednisolone and urokinase pulses therapy for severe Henoch-Schoenlein nephritis. Pediatrics 111:785–789
National Heart, Lung and Blood Institute, Bethesda, Maryland (1987) Report of the Second Task Force on Blood Pressure Control in children. Pediatrics 79:1–25
Andreoli SP, Bergstein JM (1989) Treatment of severe IgA nephropathy in children. Pediatr Nephrol 3:248–253
Gianviti A, Trompeter RS, Barratt TM, Lythgoe MF, Dillon M (1996) Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis. Arch Dis Child 75:186–190
Vassalli P, McCluskey RT (1964) The pathogenic role of fibrin deposition in immunologically induced glomerulonephritis. Ann NY Acad Sci 116:1052–1054
Miura M, Endoh M, Nomoto Y, Sakai H (1989) Long-term effect of urokinase therapy in IgA nephropathy. Clin Nephrol 32:209–216
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kawasaki, Y., Suzuki, J., Murai, M. et al. Plasmapheresis therapy for rapidly progressive Henoch-Schönlein nephritis. Pediatr Nephrol 19, 920–923 (2004). https://doi.org/10.1007/s00467-004-1514-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-004-1514-0